Comparison of clinical characteristics, species composition and antimicrobial resistance in extrapulmonary nontuberculous mycobacteria with or without HIV co-infection
Abstract
Abstract Background Clinical nontuberculous mycobacteria (NTM) isolates are increasing annually. Extrapulmonary specimens lack typical imaging features, hampering differentiation from Mycobacterium tuberculosis . HIV infection influences NTM species composition, yet stratified data on extrapulmonary NTM isolates—particularly the drivers of resistance differences—remain limited. Methods We retrospectively analyzed mycobacterial culture records from Shenzhen Third People’s Hospital (2020–2025). A total of 135 extrapulmonary NTM isolates were stratified by HIV status. Demographics, susceptibility to eight antimicrobials, species distribution, and specimen types were compared. Within-species subgroup analysis identified the primary resistance driver. Results Annual NTM isolates increased from 496 in 2020 to 1,012 in 2025, while the overall proportion remained stable. HIV co-infection was common (65/135, 47.8%). Species composition differed markedly: Mycobacterium avium complex (MAC) dominated HIV-positive cases (>93%), while rapidly growing mycobacteria were frequent in HIV-negative cases (40.0%). Rifampin resistance was most prevalent (91.38%). Before species adjustment, the risk of levofloxacin resistance was significantly higher in the HIV-positive group (RR = 1.56, P = 0.005). However, within-species analysis revealed no significant differences after Bonferroni correction, confirming that the observed intergroup difference in resistance was driven by species composition…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.